JPMorgan upgraded Argan (AGX) from 'neutral' to 'overweight' with a new price target of $550.00 after the company reported Q4 EPS of $3.47, significantly beating the expected $1.99. The company also achieved Q4 revenue of $262.1 million with a net margin of 13.1% and ROE of 31.4%. This upgrade reflects the company's strong financial performance.
